Tag: Clinical Trials
NIH Trial Underway for Universal Flu Vaccine
Phase 1 trial testing both intranasal and intramuscular administration
One in 10 Pain Meds Make It Through Development Process
More drugs with high abuse potential made it through the development process than new drugs with low abuse potential
Women Remain Underrepresented in Clinical Trials
Gap seen in cardiovascular, psychiatry, and cancer trial participation versus national prevalence disease data
New Alzheimer Disease Drug Delivers Disappointing Results
Trial was the first to test a drug meant to delay or halt mental decline in people who have a genetic predisposition
Disruption to Oncology Clinical Trials Seen Early in Pandemic
Numbers of new patient accruals and newly activated trials decreased early on, followed by progressive recovery
ASCO: ACA Medicaid Expansion Has Increased Access to Cancer Trials
Proportion of SWOG trial participants who had Medicaid insurance increased by 20 percent per year after ACA Medicaid expansion
ASCO: Black Patients With Metastatic Breast Cancer Willing to Consider Clinical Trials
40 percent of respondents reported that care team had not discussed trials; concerns about side effects, effectiveness limit participation
NIH Launches Clinical Trial of Epstein-Barr Virus Vaccine
The phase 1 trial is expected to last four years and enroll 40 participants
Use of Extrapolation Common in FDA New Drug Approvals
Extrapolation of the findings from pivotal clinical trials to the approved indication most common for disease severity
Less Than Half of U.S.-Based Clinical Trials Report Race/Ethnicity
Median combined enrollment of minority race/ethnicity groups was below corresponding population demographics based on census estimates
